CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Cytokinetics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
May 8, 2024Polymorphs Of (R)-N-(5-(5-Ethyl-1,2,4-Oxadiazol-3-Yl)-2,3-Dihydro-1H-Inden-1-Yl)-1-Methyl-1H-Pyrazole-4-Carboxamide1
Aug 14, 2019Salt Of Omecamtiv Mecarbil And Process For Preparing Salt1

Top competitors of Cytokinetics

Top competitors of Cytokinetics based on patent oppositions.